Shu X - Search Results

1

Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis.

Qiu J, Zhang H, Xu D, Li L, Xu L, Jiang Y, Wen T, Lu S, Meng F, Feng L, Shu X. Qiu J, et al. Among authors: shu x. J Oncol. 2022 May 14;2022:7306198. doi: 10.1155/2022/7306198. eCollection 2022. J Oncol. 2022. PMID: 35607328 Free PMC article.

2

Aggregate human health risk assessment from dust of daily life in the urban environment of Beijing.

Xu LY, Shu X. Xu LY, et al. Among authors: shu x. Risk Anal. 2014 Apr;34(4):670-82. doi: 10.1111/risa.12168. Epub 2014 Jan 20. Risk Anal. 2014. PMID: 24444332

3

Association of hormone replacement therapy with increased risk of meningioma in women: A hospital-based multicenter study with propensity score matching.

Shu X, Jiang Y, Wen T, Lu S, Yao L, Meng F. Shu X, et al. Asia Pac J Clin Oncol. 2019 Oct;15(5):e147-e153. doi: 10.1111/ajco.13138. Epub 2019 Feb 13. Asia Pac J Clin Oncol. 2019. PMID: 30761745

4

Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis.

Feng Y, Jiang Y, Wen T, Meng F, Shu X. Feng Y, et al. Among authors: shu x. Pathol Oncol Res. 2020 Apr;26(2):1063-1072. doi: 10.1007/s12253-019-00657-6. Epub 2019 Apr 22. Pathol Oncol Res. 2020. PMID: 31011911 Free article.

5

The Relative Risk of Immune-Related Liver Dysfunction of PD-1/PD-L1 Inhibitors Versus Chemotherapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials.

Deng S, Yang Q, Shu X, Lang J, Lu S. Deng S, et al. Among authors: shu x. Front Pharmacol. 2019 Sep 23;10:1063. doi: 10.3389/fphar.2019.01063. eCollection 2019. Front Pharmacol. 2019. PMID: 31607917 Free PMC article.

6

A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma.

Feng Y, Feng Q, Xu L, Jiang Y, Meng F, Shu X. Feng Y, et al. Among authors: shu x. J Oncol. 2019 Dec 6;2019:2654296. doi: 10.1155/2019/2654296. eCollection 2019. J Oncol. 2019. PMID: 31885571 Free PMC article.

7

A novel prognostic biomarker for muscle invasive bladder urothelial carcinoma based on 11 DNA methylation signature.

Feng Y, Jiang Y, Feng Q, Xu L, Jiang Y, Meng F, Shu X. Feng Y, et al. Among authors: shu x. Cancer Biol Ther. 2020 Dec 1;21(12):1119-1127. doi: 10.1080/15384047.2020.1833811. Epub 2020 Nov 5. Cancer Biol Ther. 2020. PMID: 33151129 Free PMC article.

8

Risk of Death in Colorectal Cancer Patients with Multi-morbidities of Metabolic Syndrome: A Retrospective Multicohort Analysis.

Feng Q, Xu L, Li L, Qiu J, Huang Z, Jiang Y, Wen T, Lu S, Meng F, Shu X. Feng Q, et al. Among authors: shu x. Cancer Res Treat. 2021 Jul;53(3):714-723. doi: 10.4143/crt.2020.481. Epub 2020 Dec 2. Cancer Res Treat. 2021. PMID: 33285055 Free PMC article.

9

Hormone replacement therapy in relation to the risk of colorectal cancer in women by BMI: a multicentre study with propensity score matching.

Xu L, Li L, Xu D, Qiu J, Feng Q, Wen T, Lu S, Meng F, Shu X. Xu L, et al. Among authors: shu x. Int J Clin Oncol. 2022 Apr;27(4):765-773. doi: 10.1007/s10147-021-02110-8. Epub 2022 Jan 13. Int J Clin Oncol. 2022. PMID: 35025014

10

Synergism between the metabolic syndrome components and cancer incidence: results from a prospective nested case-control study based on the China Health and Retirement Longitudinal Study (CHARLS).

Li L, Meng F, Xu D, Xu L, Qiu J, Shu X. Li L, et al. Among authors: shu x. BMJ Open. 2022 Sep 17;12(9):e061362. doi: 10.1136/bmjopen-2022-061362. BMJ Open. 2022. PMID: 36115664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,745 results

Search Page

Filters